Browse News
Filter News
Found 573,361 articles
-
Syngenta Commits $2 Billion and Sets New Targets for Innovation to Tackle Climate Change
10/22/2019
Syngenta dedicates $2 billion over five years to innovation specifically targeted at delivering a step change in agricultural sustainability
-
Takeda Acquires License for First-In-Class Celiac Disease Therapy from COUR Pharmaceuticals Following Positive Phase 2a Proof-of-Concept Study
10/22/2019
Late-breaking data presented from a Phase 2a trial at UEG Week 2019, Barcelona, Spain, highlights potential of investigational medicine to prevent gluten induced immune activation in patients with celiac disease
-
Prof. Matthias Mann Joins PharmaFluidics Advisory Board
10/22/2019
PharmaFluidics NV, an innovative player in the field of proteomics with the unique high-resolution µPAC™ micro-Chip chromatography products, is pleased to welcome Prof. Dr. Matthias Mann as member of its Advisory Board..
-
Neurotechnology Ranks First in Latest MINEX III Results
10/22/2019
Neurotechnology's template generator and matcher top the NIST MINEX, ranking as the most interoperable and accurate fingerprint recognition system
-
Boston Scientific Announces Cash Tender Offer for Up To $1.0 Billion of Its Outstanding Debt Securities
10/22/2019
Boston Scientific Corporation announced the commencement of a cash tender offer for up to $1.0 billion aggregate principal amount of the outstanding senior notes listed in the table below
-
Centene and WellCare Announce Approval of Pending Transaction by New York State Insurance and Healthcare Departments
10/22/2019
Centene Corporation and WellCare Health Plans, Inc. announced that the New York Department of Financial Services and Department of Health have each approved Centene's pending indirect acquisition of New York domiciled WellCare insurance subsidiaries, bringing the total number of states to approve the transaction to 25..
-
Comprehensive Study of Americans' Attitudes on Health Care Uncovers Deep Concern About Costs, Candidate Proposals and the Opioid Epidemic
10/22/2019
The Physicians Foundation released its biennial Survey of America's Patients, revealing the biggest hurdles facing Americans in our country's expensive and hard to navigate health care system.
-
Centene Corporation Reports 2019 Third Quarter Results
10/22/2019
2019 Third Quarter Diluted EPS of $0.23; Adjusted Diluted EPS of $0.96
-
OraSure Technologies Earnings Conference Call Invitation2019 Third Quarter Earnings Conference Call Wednesday, November 6, 2019, 5:00 p.m. ET
10/22/2019
OraSure Technologies, Inc. has scheduled its regular earnings conference call covering 2019 third quarter financial results, updated financial guidance and certain business developments for 5:00 pm ET on Wednesday, November 6, 2019..
-
OrigiMed: The largest cohort study on HBV-Related hepatocellular carcinoma in China released in Cell
10/22/2019
The world-class journal Cell, an international high-impact journal, published the article "Integrated Proteogenomic Characterization of HBV-Related Hepatocellular Carcinoma in China."
-
HCmed introduces Pulmogine in the 2019 ERS Congress
10/22/2019
HCmed Innovations Co., Inc., a drug-device combination company focused on inhalation therapy, presented its latest brand, Pulmogine, in the 2019 ERS International Congress.
-
ASLAN Pharmaceuticals Enrolls First Patient in Proof-of-Concept Study for ASLAN004 Targeting Atopic Dermatitis
10/22/2019
Multiple ascending dose study will assess the safety and efficacy of ASLAN004 in patients with moderate to severe atopic dermatitis
-
Bicycle Therapeutics Expands Neuroscience Collaborations to Include Oxford University’s Oxford Drug Discovery Institute
10/22/2019
Bicycle to collaborate with ODDI, an organization with deep expertise in the molecular pathology of Alzheimer’s disease and CNS drug development
-
We round out the month of October and start the month of November with four PDUFA dates on the U.S. Food and Drug Administration’s calendar. Here’s a look.
-
One of the challenges of getting an employer to pay attention to your cover letter is that letters tend to look uninviting with large expanses of gray type broken up only by paragraphs.
-
Generational Priorities: What Baby Boomers, Gen-Xers and Millennials Think Makes an Ideal Employer
10/21/2019
When it comes to specific attributes, having the opportunity to do interesting and meaningful work, securing a competitive salary and having access to quality health benefits were the most important. Here are some differences when it comes to generational priorities. -
Tucatinib is an oral tyrosine kinase inhibitor that is highly selective for HER2 without significantly inhibiting EGFR.
-
Clinical Catch-Up: October 14-18
10/21/2019
Last week was busy for clinical trial news. Here’s a look. -
Thanks to a new regulatory win, AstraZeneca’s Farxiga can now be used to reduce the risk of hospitalization for heart failure in type 2 diabetes patients with cardiovascular disease and with certain risk factors.
-
Verseau’s lead product targets PSGL-1 (P-selectin glycoprotein ligand-1), which is an adhesion molecule involved in immune cell trafficking in response to tissue injury or inflammation, according to the company.